Hypouricaemic and nephroprotective effects of Poria cocos in hyperuricemic mice by up-regulating ATP-binding cassette super-family G member 2

References

• Altınok-Yipel F, Ozan Tekeli İ, Özsoy ŞY, Güvenç M, Kaya A, Yipel M. 2020. Hepatoprotective activity of linalool in rats against liver injury induced by carbon tetrachloride. Int J Vitam Nutr Res. 90(3–4):302–308.
   PubMed Web of Science ®Google Scholar
• Barkas F, Elisaf M. 2018. National hyperlipidemia management policies improve lipid target attainment in clinical practice. Curr Med Res Opin. 34(2):301–303.
   PubMed Web of Science ®Google Scholar
• Bo MM, Cao KG. 2008. Treatment based on LuoBing theory of hyperuricemia and kidney damage. J New Chin Med. 5:1–2.
   Google Scholar
• Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. 2009. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 76(4):422–427.
   PubMed Web of Science ®Google Scholar
• Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YM, Young JD, et al. 2015. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Comm. 6:7489.
   PubMed Web of Science ®Google Scholar
• Chen M, Yokose C, Rai SK, Pillinger MH, Choi HK. 2019. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey, 2007–2016. Arthritis Rheumatol. 71(6):991–999.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu X, Zhang L, Zeng F. 2009. Chain conformation and anti-tumor activities of phosphorylated (1 → 3)-β-d-glucan from Poria cocos. Carbohydr Polym. 78(3):581–587.
   Web of Science ®Google Scholar
• Gagnon JK, Law SM, Brooks CR. 2016. Flexible CDOCKER: development and application of a pseudo-explicit structure-based docking method within CHARMM. J Comput Chem. 37(8):753–762.
   PubMed Web of Science ®Google Scholar
• Hu K, Guan W, Bi Y, Zhang W, Li L, Zhang B, Liu Q, Song Y, Li X, Duan Z, et al. 2020. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. DOI:10.1016/j.phymed.2020.153242.
   Web of Science ®Google Scholar
• Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, Yamanashi Y, Kasuga H, Nakashima H, Nakamura T, et al. 2012. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 3:764.
   PubMed Web of Science ®Google Scholar
• Jackson SM, Manolaridis I, Kowal J, Zechner M, Taylor N, Bause M, Bauer S, Bartholomaeus R, Bernhardt G, Koenig B, et al. 2018. Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nat Struct Mol Biol. 25(4):333–340.
   PubMed Web of Science ®Google Scholar
• Janssen CA, Oude VM, Vonkeman HE, Krol M, van de Laar M. 2018. A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in the Netherlands. Clin Rheumatol. 37(8):2291–2296.
   PubMed Web of Science ®Google Scholar
• Kong LD, Cai Y, Huang WW, Cheng CH, Tan RX. 2000. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol. 73(1–2):199–207.
   PubMed Web of Science ®Google Scholar
• Kuo CF, Grainge MJ, Zhang W, Doherty M. 2015. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 11(11):649–662.
   PubMed Web of Science ®Google Scholar
• Kuwata H, Okamura S, Hayashino Y, Tsujii S, Ishii H. 2017. Serum uric acid levels are associated with increased risk of newly developed diabetic retinopathy among Japanese male patients with type 2 diabetes: a prospective cohort study (diabetes distress and care registry at Tenri [DDCRT 13]). Diabetes Metab Res Rev. 33(7):e2905.
   Web of Science ®Google Scholar
• Lee MH, Graham GG, Williams KM, Day RO. 2008. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf. 31(8):643–665.
   PubMed Web of Science ®Google Scholar
• Lee S, Lee D, Lee SO, Ryu J, Choi S, Kang KS, Kim KH. 2017. Anti-inflammatory activity of the sclerotia of edible fungus, Poria cocos Wolf and their active lanostane triterpenoids. J Funct Food. 32:27–36.
   Web of Science ®Google Scholar
• Lee S, Lee S, Roh H, Song S, Ryoo R, Pang C, Baek K, Kim K. 2018. Cytotoxic constituents from the sclerotia of Poria cocos against human lung adenocarcinoma cells by inducing mitochondrial apoptosis. Cells. 7(9):116.
   PubMed Web of Science ®Google Scholar
• Lee SR, Lee S, Moon E, Park H, Park HB, Kim KH. 2017. Bioactivity-guided isolation of anti-inflammatory triterpenoids from the sclerotia of Poria cocos using LPS-stimulated Raw264.7 cells. Bioorg Chem. 70:94–99.
   PubMed Web of Science ®Google Scholar
• Li GH, Shen YM, Zhang KQ. 2005. Nematicidal activity and chemical component of Poria cocos. J Microbiol. 43:17–20.
   PubMed Web of Science ®Google Scholar
• Li JM, Zhang X, Wang X, Xie YC, Kong LD. 2011. Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice. Eur J Pharmacol. 666(1–3):196–204.
   PubMed Web of Science ®Google Scholar
• Li T, Hou C, Chang CL, Yang W. 2011. Anti-hyperglycemic properties of crude extract and triterpenes from Poria cocos. Evid Based Complement Altern Med. 2011:1–8.
   Web of Science ®Google Scholar
• Liang D, Yong T, Chen S, Xie Y, Chen D, Zhou X, Li D, Li M, Su L, Zuo D. 2018. Hypouricemic effect of 2,5-dihydroxyacetophenone, a computational screened bioactive compound from Ganoderma applanatum, on hyperuricemic mice. Int J Mol Sci. 19(5):1394.
   PubMed Web of Science ®Google Scholar
• Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. 2015. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015:762820.
   PubMed Web of Science ®Google Scholar
• Liu Z, Du J, Yan X, Zhong J, Cui L, Lin J, Zeng L, Ding P, Chen P, Zhou X, et al. 2018. TCMAnalyzer: a chemo- and bioinformatics web service for analyzing traditional Chinese medicine. J Chem Inf Model. 58(3):550–555.
   PubMed Web of Science ®Google Scholar
• Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, et al. 2014. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep. 4:3755.
   PubMed Web of Science ®Google Scholar
• Qiu XT. 2008. Experience of clinical practices of Yongjie Zhang on gouty arthritis. China J Basic Med Tradit Chin Med. 14:301–305.
   Google Scholar
• Rai SK, Avina-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, Choi HK. 2017. The rising prevalence and incidence of gout in British Columbia, Canada: population-based trends from 2000 to 2012. Semin Arthritis Rheum. 46(4):451–456.
   PubMed Web of Science ®Google Scholar
• Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:13.
   PubMed Web of Science ®Google Scholar
• Sakurai H. 2013. Urate transporters in the genomic era. Curr Opin Nephrol Hypertens. 22(5):545–550.
   PubMed Web of Science ®Google Scholar
• Song P, Wang H, Xia W, Chang X, Wang M, An L. 2018. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep. 8(1):4314.
   PubMedGoogle Scholar
• Tang J, Nie J, Li D, Zhu W, Zhang S, Ma F, Sun Q, Song J, Zheng Y, Chen P. 2014. Characterization and antioxidant activities of degraded polysaccharides from Poria cocos sclerotium. Carbohydr Polym. 105:121–126.
   PubMed Web of Science ®Google Scholar
• Taylor N, Manolaridis I, Jackson SM, Kowal J, Stahlberg H, Locher KP. 2017. Structure of the human multidrug transporter ABCG2. Nature. 546(7659):504–509.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang W, Tang C, Xiao J, Xie B, Sun Z. 2018. Synergistic effect of B-type oligomeric procyanidins from lotus seedpod in combination with water-soluble Poria cocos polysaccharides against E. coli and mechanism. J Funct Food. 48:134–143.
   Web of Science ®Google Scholar
• Xu X, Hu J, Song N, Chen R, Zhang T, Ding X. 2017. Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis. BMC Nephrol. 18(1):27.
   PubMedGoogle Scholar
• Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T. 2013. TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 41(Database issue):D1089–D1095.
   PubMedGoogle Scholar
• Yan HF, Dai XD, Fan KT, Wang Y. 2016. Research on medication regularity of traditional Chinese medicine based on hyperuricemia patents. Chin Herb Med. 8(4):376–381.
   Web of Science ®Google Scholar
• Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, Wu CY, Hung SI, Chung WH. 2015. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med. 175(9):1550–1557.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang DM, Liu JH, Hu LS, Xue QC, Ding XQ, Kong LD. 2015. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice. J Ethnopharmacol. 169:49–59.
   PubMed Web of Science ®Google Scholar
• Zhang G, Liu H, Xia Q, Li J, Lü H, Zhang Q, Yao Z. 2004. Anti-rejection effect of ethanol extract of Poria cocos Wolf in rats after cardiac allograft implantation. Chin Med J (Engl). 117(6):932–935.
   PubMed Web of Science ®Google Scholar